IGKV2D-26 and breast carcinoma: The breast cancer cell line MDA-MB-231 is highly invasive, and blocking experiments with anti-α5 or anti-β1 integrin, as well as the specific knockdown α5-integrin, dramatically decreased the invasiveness of these cell lines into the ECM.